Hydroxydione sodium succinate

This classification denotes an anesthetic agent with the molecular formula C25H35O6.Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 53J8I8O5EW, chemically known as 21-hydroxypregnane-3,20-dione sodium hemisuccinate but more generally known as hydroxydione sodium, which bears US NIH Compound Identifier 5868. European Medicines Agency schedules Hydroxydione sodium succinate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08078MIG. The term HYDROXYDIONE SODIUM SUCCINATE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 16, No. 3 1962, List 4). Most nations, for tariff and trade purposes, schedule hydroxydione sodium succinate under HS 29171990 and SITC 51389. As of Q4 2014, HYDROXYDIONE SODIUM SUCCINATE remains US FDA's Preferred Term for this commodity. Hydroxydione sodium succinate bears US NLM identifiers UMLS ID C0042621 and NCI Concept Code C75960. SMILES: C[C@]12CCC(=O)C[C@H]1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@@H]4C(=O)COC(=O)CCC(=O)[O-])C.[NA+].